Introduction
============

Peripheral nerve injury is common in the clinic and often leaves pain or other motor and sensory nerve defects[@B1]. The connection between the nerve fiber and the distal organ can be negatively affected or lost, and for some clinical patients, the distal organ undergoes atrophy. Its recovery is always incomplete, often costs too much and leaves personal hardship[@B2]. In the past decades, minimally invasive surgery was widely applied in the clinic, but peripheral nerve injury has still seen no significant improvement[@B3]. In the process of peripheral nerve repair and regeneration, Schwann cells are crucial factors that clear up cell residue due to their phagocytic function, providing neurons with nutritional factors and suitable space[@B4]. Recently, Schwann cells were recognized in the repair of the peripheral nerve system, including cell migration, viability, proliferation, and nutritional factor secretion activity[@B5]. Thus, it is very important and crucial to improve the biofunction of Schwann cells.

Ultrasound has been widely used in the clinic for decades and is acknowledged as harmless. Some studies reveal that ultrasound accelerates injured tissue regeneration or repair, such as bone fracture and tendon healing[@B6]. In the biological fields, ultrasound is also widely used in many in vitro studies and is known to enhance cell proliferation or alter protein expression in various types of cells, such as endothelial cells, osteoblasts, chondrocytes, and fibroblasts[@B7]-[@B9]. To date, even though many ultrasound-related proteins have been reported using in vitro studies[@B10], the mechanism of its biological effect is largely unknown.

Low-intensity pulsed ultrasound (LIPUS) sends mechanical energy to the biological tissue in the form of pressure wave propagation to the micro-pressure as a medical diagnosis and treatment tool. LIPUS has been applied to promote fracture healing and callus formation in the treatment of fractures. As a mechanical stimulation, it improves chondrocytes proliferation and survival[@B11], [@B12], accelerates fracture healing[@B13], and promotes bone maturation in clinical distraction osteogenesis cases[@B14]. LIPUS establishes a mechanical strain, which stimulates the callus healing and periosteal bone formation. At present, the application of LIPUS is still controversial. The intensity and time of LIPUS and its side effects in clinical application do not have enough research for its support. Many studies focus on Schwann cells to examine the effect of LIPUS on nerve regeneration. However, the recovery of injured nerve is generally poor.

When the peripheral nerve is cut or crushed, there are many stress reactions, such as changes in the neurotrophic factors, cytokines, adhesion molecules and growth-promoting molecules. The neurotrophic factor expression is related to the reaction and viability of the Schwann cells to attenuate the damage. Cyclins are regulatory subunits of CDKs (Cyclin-dependent kinases) that control the cells throughout the cell cycle, with their protein levels change periodically as an adapting requirement. During the regeneration process, Schwann cells dedifferentiate, reenter the cell cycle (controlled by the Cyclin/CDK complexes) and increase several-fold in number in the distal stump. We used an EdU (5-Ethynyl-2\'-deoxyuridine) staining method to study Schwann cell proliferation after irradiation by LIPUS and examined the GSK-3β/β-catenin/Cyclin D1 pathway to study the possible mechanism.

GSK-3β (Glycogen synthase kinase-3β), a cytoplasmic serine/threonine protein kinase, plays a central role in a number of important development signaling pathways. GSK-3β regulates Cyclin D1 gene transcription by the phosphorylation of β-catenin[@B15]. We pay particular attention to GSK-3β, with reference to Cyclin D1, because this serine/threonine protein kinase regulates Cyclin D1 gene transcription by the phosphorylation of β-catenin[@B15].

Based on the above findings, we investigated whether LIPUS promotes Schwann cell viability and proliferation and examined whether the GSK-3β/β-catenin/Cyclin D1 signaling pathway is the possible mechanism.

Materials and methods
=====================

Ethics statement
----------------

All the experimental procedures were approved by the Animal Care and Ethic Committee and Use Committee of Harbin Medical University (HMUIRB-2008-06), and complied with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Cell culture and purification
-----------------------------

Schwann cells were extracted from the sciatic nerve of postnatal 1-3 days\' Sprague-Dawley rats[@B16]. All the neonatal male Sprague-Dawley rats were obtained from the Second Affiliated Hospital of Harbin Medical University. Both sides of neonatal rats\' sciatic nerve were removed and then were cut into 2-3 mm small broken pieces. The nerve pieces were mixed with 0.25% trypsin for shaking digestion in a 37°C water bath for 10 min and were mixed thoroughly with 10% fetal serum culture DMEM to terminate the digestion. The mixture was centrifuged at 1000 revolutions per minute for 5 min, and then, the supernatant was discarded and 10% serum culture medium was added. The cells were plated on the culture flasks and were allowed to adhere for 2 days at 37°C. Under the microscope, we observed that cells adhered to the bottom, and then, we digested the cells with trypsin.

LIPUS treatment
---------------

Schwann cells were plated onto 6-well plates at an initial density of 2 × 10^4^ per well. We divided them into two groups as follows: the control group (Schwann cells without LIPUS treatment) and the ultrasound group (Schwann cells with LIPUS treatment at 27.25 W/cm^2^ for 10 min once a day, which lasted 5 days). The transducer was 75% ethanol, and the culture plates were put on the transducer.

3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay
-----------------------------------------------------------------------------

Schwann cells were plated onto 96-well plates at a density of 1×10^3^ cells per well. When the cells were treated with LIPUS for 5 days, we added 20 µl of a 0.5% MTT solution, and the cells were incubated for 4 h. Then, the culture solution was discarded, and the Schwann cells were washed 3 times with PBS. We added 150 µl of Dimethyl Sulfoxide in to every well and put the plates on rocking bed that oscillated for 10 min at low speed. The absorbance value was detected on the enzyme-linked immune detector at 490 nm[@B17].

Cell proliferation assay
------------------------

Schwann cell proliferation was detected using the EdU staining kit and flow cytometry. EdU, as a thymidine analogue, inserts into DNA molecules during replication. Based on the EdU and dye conjugation reaction, EdU staining effectively detects the percentage of cells in the S phase and detects cell proliferation efficiently and rapidly. After the Schwann cells were treated with LIPUS for 5 days, we added 25 µM 5-Ethynyl-2\'-deoxyuridine into the well and co-incubated with serum free DMEM. The Schwann cells were rinsed with a phosphate buffer solution for 5 min, and this was repeated twice. Then, they were immobilized with 4% paraformaldehyde for 30 min. The Schwann cells were treated with glycine for 5 min and rinsed with PBS for 5 min. The Schwann cells were treated with the Apollo staining solution EdU staining kit for 30 min and were treated with 4,6-diamidino-2-phenylindole staining for 15 min. Lastly, the Schwann cells were rinsed with PBS 3 times. We observed the cells using a fluorescence microscope in 5 horizons.

Flow cytometry
--------------

After the Schwann cells were treated with LIPUS for 5 days, the Schwann cells were harvested and washed twice with PBS. Then, we fixed the cells with 75% cold ethanol for 30 min. We retreated the cells with PBS and stained the cells with PI for 30 min. Finally, the cells were analyzed for cell cycle detection by an automatic flow cytometry FACS Calibur.

Real-time PCR
-------------

The Schwann cells were seeded in 6-well plates and were treated with LIPUS for 5 days. Total RNA was extracted using the Trizol reagent, and its concentration was determined spectrophotometrically at 260 nm with a purity of an A260/A280 ratio that ranged from 1.8 to 2.1[@B18]. We obtained the cDNA according to reverse transcription using the Fast Quant RT Kit manufacturer\'s protocol. Real-time PCR (Polymerase Chain Reaction) was performed using the SYBR Green PCR Master Mix Kit on a 7500 FAST real-time PCR system for 40 cycles, with GAPDH as the internal control[@B19]. The primers used in the study are provided in Table [1](#T1){ref-type="table"}.

Immunofluorescence staining
---------------------------

The cultured neonatal Schwann cells were fixed with 4% paraformaldehyde dissolved in PBS. The cells were penetrated and incubated for 2 h by a blocking solution, including 1% BSA and 0.1% Triton-X in PBS. The cells were incubated with the primary antibodies, including Cyclin D1 and S100 (Schwann marker), overnight at 4°C[@B20]. The following day, the cells were incubated with the appropriate secondary antibody for 1 h at room temperature. The nuclei were stained for 20 min at room temperature. Finally, we detected the cells under a fluorescence microscope.

Western blot
------------

After LIPUS treatment, the Schwann cells were lysed with 80μl of lysis buffer per well on ice containing 50 mM Tris-base, 150 mM NaCl, 1 mM EDTA, 1 mM sodium orthovanadate, 20 mM NaF, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate, pH 7.4, and 1% protease inhibitors. The protein concentration was determined by the BCA protein assay kit[@B21]. Equal amounts of protein samples were separated by 10% SDS-PAGE and were transferred onto nitrocellulose membranes[@B22]. After blocking with 5% non-fat milk, the membranes were incubated with primary antibodies against GSK-3β, p-GSK-3β, FGF, NGF, BDNF, GDNF and β-catenin (Abcam, Cambridge, MA, USA), Cyclin D1 and GAPDH, diluted at 1:500 in PBS buffer, overnight at 4°C. The membranes were washed in the PBS with 0.05% Tween 20 and were incubated with a fluorescence-conjugated anti-rabbit IgG secondary antibody (1:10000) for 1 h[@B23]. After the incubation with the secondary antibody, the protein bands were quantified using Odyssey v1.2 software, and we measured with the target band intensity compared to GAPDH[@B24].

Data analysis
-------------

All the data are presented as the mean ± SEM, and multiple comparisons were analyzed with one-way analysis of variance (ANOVA) by GraphPad Prism 5.0. P\<0.05 was considered statistically significant.

Results
=======

Effect of LIPUS on Schwann cell viability
-----------------------------------------

S100 is the special marker of Schwann cells. The purity of the Schwann cells was more than 95% (Figure [1](#F1){ref-type="fig"}A). The ultrasound transmitter was refitted by the Chinese Academy of Science, Institute of Acoustics Research Station, including 20 grades, and its electric power ranged from 6-30 W accompanied by an ultrasound power of 7.2\~89.0 W/cm^2^. To get the optimal ultrasound intensity, we chose grades 3, 5, 7, 8, 9, and 10, and their ultrasound intensity were, respectively, 9.0 W/cm^2^, 16.0 W/cm^2^, 23.0 W/cm^2^, 27.5 W/cm^2^, 32.5 W/cm^2^, 35.0 W/cm^2^, and 40.0 W/cm^2^. The results showed that an ultrasound intensity of 27.5 W/cm^2^ and 32.5 W/cm^2^ increased the OD value significantly compared with the control group (0 W/cm^2^) (Figure [1](#F1){ref-type="fig"}B). The 27.5 W/cm^2^ ultrasound intensity optimally promoted cell viability, and thus, the subsequent experiments used this intensity as the ultrasound group. In Figure [1](#F1){ref-type="fig"}C, the cells were treated for 10 min per day for 5 days. The viability of the Schwann cells increased compared with the non-LIPUS treated group.

Effects of LIPUS on secreting growth factors and neurotrophic factors
---------------------------------------------------------------------

To observe the biofunction of LIPUS on the Schwann cells, we detected the expression of growth factors and neurotrophic factors. There are four important factors that have crucial functions in Schwann cell activity, including FGF, NGF, BDNF, and GDNF. NGF directly regulates the structure via targeting the proteins that comprise myelin[@B25], and FGF enhances the efficacy of Schwann cells. BDNF and GDNF regenerate axons after immediate nerve repair[@B26]. After the cells were treated with LIPUS, the protein and mRNA levels of FGF, NGF, BDNF and GDNF increased significantly compared with the control group (Figure [2](#F2){ref-type="fig"}A-[2](#F2){ref-type="fig"}H).

Effects of LIPUS on Schwann cell proliferation
----------------------------------------------

Cell proliferation was detected with EdU staining. The Ultrasound group was treated by 1 MHz LIPUS with 27.5 W/cm^2^. Our data showed that there was more 5-Bromo-2-deoxyuridine participating in DNA replication in the LIPUS group (Figure [3](#F3){ref-type="fig"}A). The statistical data showed that LIPUS significantly stimulated Schwann cell proliferation (Figure [3](#F3){ref-type="fig"}B).

Effects of LIPUS on Cyclin D1 expression
----------------------------------------

To further explore the molecular mechanism of LIPUS on cell proliferation, we found that the protein and mRNA level of Cyclin D1 in LIPUS group was significantly increased (Figure [4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B). The immunostaining figure also showed that there was more Cyclin D1 expressed in the Schwann cells (Figure [4](#F4){ref-type="fig"}C).

LIPUS promotes Schwann cell viability and proliferation via the GSK-3β/β-catenin signaling pathway
--------------------------------------------------------------------------------------------------

Previous studies indicate that the GSK-3β/β-catenin signaling pathway regulates the expression of Cyclin D1. In our study, the GSK-3β activity was inhibited in the LIPUS group as demonstrated by the increased level of p-GSK-3β (serine-9 phosphorylation) and the ratio of the p-GSK-3β/GSK-3β level (Figure [5](#F5){ref-type="fig"}A-[5](#F5){ref-type="fig"}C). Meanwhile, the mRNA and protein expression of β-catenin increased in the LIPUS group (Figure [5](#F5){ref-type="fig"}D and [5](#F5){ref-type="fig"}E). Thus, the LIPUS enhanced Schwann cell proliferation by activating the GSK-3β/β-catenin pathway. The data showed that the expression of p-GSK-3β, GSK-3β, β-catenin and Cyclin D1 were restored by co-treating with SB216763, a GSK-3β inhibitor (Figure [5](#F5){ref-type="fig"}A-[5](#F5){ref-type="fig"}G).

The immunofluorescence staining of Cyclin D1 and the EdU staining also showed the SB216763 reversed the effects of LIPUS (Figure [6](#F6){ref-type="fig"}A and [6](#F6){ref-type="fig"}B). The results showed that the GSK-3β inhibitor reversed the effects of LIPUS on Schwann cells (Figure [7](#F7){ref-type="fig"}A). We further detected the cell viability by flow cytometry, and the results showed that LIPUS increased the amount and percentage of cells in S phase (Figure [7](#F7){ref-type="fig"}B and [7](#F7){ref-type="fig"}C).

We inhibited β-catenin (by siRNA) and co-treated with the LIPUS. The data showed that the expression of Cyclin D1 was restored (Figure [8](#F8){ref-type="fig"}A and [8](#F8){ref-type="fig"}B). We detected the cell viability with MTT. The results showed that β-catenin inhibition reversed the function of LIPUS (Figure [8](#F8){ref-type="fig"}C). We also detected the cell proliferation after co-treated with LIPUS and β-catenin inhibition, and the results showed that β-catenin inhibition reversed the function of LIPUS (Figure [8](#F8){ref-type="fig"}D and [8](#F8){ref-type="fig"}E).

Discussion
==========

Peripheral nerve injury is divided into two types[@B27]. One type is axonotmesis, with basal lamina tubes that remain intact with axons that are disrupted. In this type, the regeneration of axons is remarkable and nerve function is restored in 3-4 weeks. Another type is neurotmesis, in which all the tissue is disrupted. In this type, function is partly restored when the two ends of the nerve are reconnected by a newly formed tissue bridge. Regeneration units, formed by axons and Schwann cells, though this bridge grow to the distal stump of the injured nerve[@B28], [@B29]. Ultrasound is effective in both types of peripheral nerve injury[@B1], [@B2], [@B30]-[@B35], which indicates that ultrasound may be useful in two methods or more to improve peripheral nerve regeneration.

In both types of peripheral nerve injury, Schwann cells play an important role. After nerve injury, Wallerian degeneration contributes an environment that helps to support the survival of the injured neurons and promote nerve regeneration. Axon regrowth and guidance are supported by Schwann cells[@B36]-[@B38]. Schwann cells up-regulate a group of neurotrophic factors (GDNF, artemin, BDNF, NT3, NGF, VEGF, etc.)[@B39], [@B40] and up-regulate the expression of the cytokines tumor necrosis factor (TNF)-a, LIF, interleukin (IL)-1a, IL-1b, LIF, and MCP-1[@B41]-[@B43].

In 2002, Crisci and Ferreira revealed that Schwann cells were stimulated by low-intensity pulsed ultrasound with an electromicrographic morphologic study and proved that low-intensity pulsed ultrasound promoted the regeneration of the sciatic nerve after neurotomy in rats[@B31]. In addition, in 2009, Zhang et al revealed that LIPUS enhanced NT3 expression[@B44]. We assumed LIPUS may use two ways to improve peripheral nerve regeneration, including the up-regulation of a group of neurotrophic factors for the first type of peripheral nerve injury and the enhancement of the proliferation of Schwann cells and up-regulation of neurotrophic factors for the second type of peripheral nerve injury. Our results support our hypothesis, which could partly reveal the mechanism of the enhancement of nerve regeneration by LIPUS.

Low-intensity pulsed ultrasound gives cells a source of energy in the form of sound pressure. Some researches indicate that LIPUS promotes fracture healing and callus formation and promotes human bone marrow stromal cells and periosteal cells, which have biological effects[@B45], [@B46]. Therefore, the present study investigated whether LIPUS affects the viability and proliferation of cultured Schwann cells. The 27.5 W/cm^2^ ultrasound intensity was used in our study. If the intensity was over 100 mW/cm^2^, the Schwann cells underwent apoptosis, and if it was below 10 mW/cm^2^, an enhanced effect was hardly found. The results proved our hypothesis. The MTT assay showed LIPUS promoted Schwann cell viability, and EdU staining showed LIPUS stimulated Schwann cell proliferation, which contributes to nerve regeneration improvement.

During the process of axon growth, Schwann cells provide neurotrophic factors for neurons, and some previous studies indicate that the promotion of the growth factors FGF and NGF or the neurotrophic factors BDNF and GNDF enhances the peripheral nerve injury recovery[@B47]-[@B49]. When the peripheral nerve was injured, the neurotrophic factors were expressed to attenuate the damage. NGF was the first identified neurotrophic factor and was purified in 1956, and it plays an important role in the development and maintenance of many neurons in both the central and peripheral nervous systems, promoting the injured peripheral nerve in adulthood. Recently, research devoted to promoting peripheral nerve regeneration by enhancing the NGF bioactivity was conducted[@B50]. FGF promotes peripheral nerve recovery by promoting axon outgrowth[@B51]. BDNF benefits Schwann cell regeneration and becomes a promising therapeutic molecule[@B52]. At the same time, GDNF promotes the precondition of Schwann cells after peripheral nerve injury[@B53]. Thus, it is necessary to explore the changes of neurotrophic factors after LIPUS treatment. Most of the neurotrophic factors are secreted proteins, and thus, we detected their expressions at the transcription level. In this study, we detected the mRNA level of some important growth factors and neurotrophic factors[@B54]. The western blot and real-time PCR assays showed that LIPUS elevated the expression of FGF, NGF, BDNF, and GDNF significantly, which enhanced axon growth.

To uncover the mechanism of the improved proliferation of Schwann cells by LIPUS, we studied the GSK-3β/β-catenin/Cyclin D1 signaling pathway. The cell cycle progresses through four sequential phases, namely, the gap 1 (G1), synthesis (S), gap 2 (G2) and mitosis (M) phases. Passage through the cell cycle is strictly controlled by cyclin/CDK complexes. During the G1 phase, the cells need to decide whether to advance toward another division or withdraw from the cell cycle into the quiescence phase (G0) in response to the extracellular signals. Cyclin D1 acts as a mitogenic signal sensor and is expressed as a delayed-early response to many mitogenic signals, which forces cells to enter the proliferative cycle from the G0 phase[@B55], [@B56]. To explore the molecular mechanism of LIPUS stimulating Schwann cell proliferation, we detected the gene and protein expression of Cyclin D1, which participates in the regulation of CDKs[@B57]. The PCR, western blotting and immunofluorescence staining assays showed LIPUS elevated the activity of Cyclin D1 in Schwann cells.

The GSK-3β/β-catenin/Cyclin D1 signaling pathway is an important regulatory signaling pathway that controls cell proliferation and differentiation[@B58]. Previous research reports that LIPUS affects GSK-3β activity through the PI3/Akt pathway in chondrocytes[@B59]. β-catenin is an intracellular regulatory transducer that is an important target of the Wnt signaling pathways. GSK-3β regulates β-catenin by regulating its nuclear accumulation, and through this pathway, GSK-3β regulates cell bio-functions, such as gene expression, protein synthesis, and cell viability[@B60], [@B61]. As a result, to further explore the molecular mechanism and the relative signaling pathway, we studied the GSK-3β/β-catenin/Cyclin D1 signaling pathway. The ratio of p-GSK-3β to GSK-3β showed that LIPUS increased the phosphorylation of GSK-3β. The phosphorylation site decides the enzymatic activity of GSK-3β, and in our study, the phosphorylation site is serine-9. We also used the selective inhibitor SB216763 to reverse the function of LIPUS. The results showed that LIPUS activated the GSK-3β/β-catenin/Cyclin D1 signaling pathway, and at the same time, when we used the GSK-3β or β-catenin inhibitor co-treated with LIPUS, the elevated Cyclin D1 was restored, which indicated that LIPUS stimulated the Schwann cell proliferation via activating the GSK-3β/β-catenin/Cyclin D1 signaling pathway.

To conclude, our research revealed that LIPUS promoted Schwann cell viability and stimulated proliferation. LIPUS promoted the bio-function of secreted growth factors and neurotrophic factors, which help axon outgrowth in the lamina tubes when the nerve is regenerating. The GSK-3β/β-catenin/Cyclin D1 signaling pathway is the possible mechanism to explain the enhancement of nerve regeneration by LIPUS.
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LIPUS

:   Low-intensity pulsed ultrasound

SCs

:   Schwann cells

FGF

:   Fibroblast Growth Factor

NGF

:   Nerve growth factor

BDNF

:   Brain-derived neurotrophic factor

GDNF

:   Glial cell-derived neurotrophic factor

CDK

:   cyclin-dependent kinase

EdU

:   5-Ethynyl-2\'-deoxyuridine

GSK-3β

:   Glycogen synthase kinase-3β.

![**Effect of LIPUS on Schwann cell viability.** (A). The purity of the extracted Schwann cells was detected by immunostaining for S100 (×200). (B). Determination of the optimal low energy pulse intensity. The Schwann cells were treated with 9.0, 16.0, 23.0, 27.5, 32.5, 35.0, and 40.0 W/cm^2^ and were assessed by MTT. \*\*p \<0.01 vs 0 W/cm^2^, \*p \<0.05; mean ± SEM. n=4. (C). The cell viability was detected with the MTT assay. \*\*\*p \<0.001 vs Control; mean ± SEM. n=4.](ijbsv14p0497g001){#F1}

![**Effects of LIPUS on the Schwann cell-secreted growth factors and neurotrophic factors.** (A-D). The protein and mRNA expressions of the growth factors (FGF, NGF) were detected by western blot and real-time PCR in the control and ultrasound groups. (E-H). Neurotrophic factor (BDNF, GDNF) protein and mRNA expression were detected by western blot and real-time PCR in the control and ultrasound groups. \*\*\*p \<0.001 vs Control, \*\*p \<0.01; mean ± SEM. n=3-5.](ijbsv14p0497g002){#F2}

![**Effects of LIPUS on the Schwann cells proliferation.** (A). The cell proliferation was detected with EdU staining (×200). (B). The statistical data of the EdU staining. \*\*\*p\<0.001 vs Control; mean ± SEM. n=5.](ijbsv14p0497g003){#F3}

![**Effects of LIPUS on the expression of Cyclin D1.** (A). Cyclin D1 expression measured by the western blot in the control, and ultrasound groups. (B). Cyclin D1 mRNA expression detected by real-time PCR in the control, and ultrasound groups. \*\*p\<0.01 vs Control; mean ± SEM. n=5. (C). The immunostaining of Cyclin D1 (×200).](ijbsv14p0497g004){#F4}

![**Results of western blot on the GSK-3β/β-catenin pathway and blocked by GSK-3β inhibitor.** (A-G). The protein and mRNA expressions of p-GSK-3β, GSK-3β and Cyclin D1 were detected by western blot and real-time PCR in the control ultrasound group. \*\*p\<0.01 vs Control, ^\#\#^p\<0.01 vs LIPUS; mean ± SEM. n=4-5.](ijbsv14p0497g005){#F5}

![**Effects on the expression of Cyclin D1 by inhibitor SB216763.** (A). The immunofluorescence staining of Cyclin D1 (×200). (B). Quantification of the Cyclin D1 fluorescence intensity. n=3. (C). EdU staining of the control, ultrasound and inhibitor SB216763 (×200). (D). The statistical data of the EdU staining. \*\*\*p\<0.001 vs Control, ^\#\#^p\<0.01 vs LIPUS; mean ± SEM. n=3.](ijbsv14p0497g006){#F6}

![**Effect on cell viability by inhibitor SB216763.** (A). The cell viability was detected using MTT assay when the cells were co-treated with LIPUS and the GSK-3β inhibitor. (B). The cell viability was detected by flow cytometry when the cells were co-treated with LIPUS and the GSK-3β inhibitor. (C). The representative image of the flow cytometry detection.](ijbsv14p0497g007){#F7}

![**Results of blocking β-catenin.** (A). The relative protein of β-catenin. (B). The relative protein of Cyclin D1. (C) The cell viability detected with MTT assay. \*\*\*p \<0.001 vs Control, ^\#\#^p \<0.01 vs LIPUS; mean ± SEM. n=3. (D). The EdU staining of co-treated with β-catenin siRNA. (E). Quantification of the EdU staining. \*\*\*p \<0.001 vs Control, ^\#\#^p \<0.01 vs LIPUS; mean ± SEM. n=3.](ijbsv14p0497g008){#F8}

![**Schematic diagram of how LIPUS promotes the Schwann cell viability and proliferation signaling pathway.** LIPUS significantly increased the expression of Cyclin D1 by activating the GSK-3β/β-catenin pathway.](ijbsv14p0497g009){#F9}

###### 

Nucleotide sequence of primers for real-time PCR.

  Gene            Primer Sequence   
  --------------- ----------------- -----------------------------
  **FGF**         Forward           5′-GACACGTGCCTTACAGCCTC-3′
                  Reverse           5′-TGGTCTGACTTTGACCCTTGG-3′
  **NGF**         Forward           5′-TGAACCAATAGCTGCCCGTG-3′
                  Reverse           5′-GTGGAGGCTGGGTGCTAAA-3′
  **BDNF**        Forward           5′-TTCGAGAGGTCTGACGACGA-3′
                  Reverse           5′-AGTCCGCGTCCTTATGGTTT-3′
  **GDNF**        Forward           5′-GTCACCAGATAAACAAGCGGC-3′
                  Reverse           5′-CCCTCTGGAATTCTCTGGGC-3′
  **Cyclin D1**   Forward           5′-AGCTGTGCATCTACACCGAC-3′
                  Reverse           5′-TGTGAGGCGGTAGTAGGACA-3′
  **GAPDH**       Forward           5′-AAGAAGGTGGTGAAGCAGGC-3′
                  Reverse           5′-TCCACCACCCAGTTGCTGTA-3′
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